These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31599131)

  • 21. Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice.
    Pellegrino MA; D'Antona G; Bortolotto S; Boschi F; Pastoris O; Bottinelli R; Polla B; Reggiani C
    Exp Physiol; 2004 Jan; 89(1):89-100. PubMed ID: 15109214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol.
    Ryall JG; Gregorevic P; Plant DR; Sillence MN; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2002 Dec; 283(6):R1386-94. PubMed ID: 12388476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular impact of clenbuterol and isometric strength training on rat EDL muscles.
    Mounier R; Cavalié H; Lac G; Clottes E
    Pflugers Arch; 2007 Jan; 453(4):497-507. PubMed ID: 17093970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of long-term treatment with dietary theobromine on rat skeletal muscles.
    Tanaka S; Sugimoto N; Ohno-Shosaku T; Madokoro S; Inaoka PT; Yamazaki T
    Mol Biol Rep; 2022 May; 49(5):3965-3973. PubMed ID: 35226259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
    Umeki D; Ohnuki Y; Mototani Y; Shiozawa K; Suita K; Fujita T; Nakamura Y; Saeki Y; Okumura S
    PLoS One; 2015; 10(6):e0128263. PubMed ID: 26053620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of hybrid-fiber types in rat soleus muscle after clenbuterol administration during hindlimb unloading.
    Picquet F; De-Doncker L; Falempin M
    Can J Physiol Pharmacol; 2004 May; 82(5):311-8. PubMed ID: 15213730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle.
    Dodd SL; Powers SK; Vrabas IS; Criswell D; Stetson S; Hussain R
    Med Sci Sports Exerc; 1996 Jun; 28(6):669-76. PubMed ID: 8784754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGF and myostatin pathways are respectively induced during the earlier and the later stages of skeletal muscle hypertrophy induced by clenbuterol, a β₂-adrenergic agonist.
    Abo T; Iida RH; Kaneko S; Suga T; Yamada H; Hamada Y; Yamane A
    Cell Biochem Funct; 2012 Dec; 30(8):671-6. PubMed ID: 22696074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic clenbuterol treatment compromises force production without directly altering skeletal muscle contractile machinery.
    Py G; Ramonatxo C; Sirvent P; Sanchez AM; Philippe AG; Douillard A; Galbès O; Lionne C; Bonnieu A; Chopard A; Cazorla O; Lacampagne A; Candau RB
    J Physiol; 2015 Apr; 593(8):2071-84. PubMed ID: 25656230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta2-adrenergic agonist-induced hypertrophy of the quadriceps skeletal muscle does not modulate disease severity in the rodent meniscectomy model of osteoarthritis.
    Tonge DP; Jones SW; Parr T; Bardsley R; Doherty M; Maciewicz RA
    Osteoarthritis Cartilage; 2010 Apr; 18(4):555-62. PubMed ID: 20060953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol.
    Gregorevic P; Williams DA; Lynch GS
    Muscle Nerve; 2002 Feb; 25(2):194-201. PubMed ID: 11870686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of a beta-agonist and a beta-agonist/beta-antagonist combination on muscle growth, body composition and protein metabolism in rats].
    Reichel K; Rehfeldt C; Weikard R; Schadereit R; Krawielitzki K
    Arch Tierernahr; 1993; 45(3):211-25. PubMed ID: 8585791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol.
    Awede BL; Thissen JP; Lebacq J
    Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E31-7. PubMed ID: 11739080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the beta2-adrenoceptor agonist prodrug BRL-47672 on cardiovascular function, skeletal muscle myosin heavy chain, and MyoD expression in the rat.
    Jones SW; Baker DJ; Gardiner SM; Bennett T; Timmons JA; Greenhaff PL
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1225-31. PubMed ID: 15243031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of beta 2-agonist administration and exercise on contractile activation of skeletal muscle fibers.
    Lynch GS; Hayes A; Campbell SP; Williams DA
    J Appl Physiol (1985); 1996 Oct; 81(4):1610-8. PubMed ID: 8904577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the beta(2)-agonist clenbuterol on the locomotor activity of rat submitted to a 14-day period of hypodynamia-hypokinesia.
    Canu M; Stevens L; Ricart-Firinga C; Picquet F; Falempin M
    Behav Brain Res; 2001 Jul; 122(1):103-12. PubMed ID: 11287081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats.
    Suzuki J; Gao M; Xie Z; Koyama T
    Acta Physiol Scand; 1997 Nov; 161(3):317-26. PubMed ID: 9401584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biochemical effects of clenbuterol: with particular reference to taurine and muscle damage.
    Waterfield CJ; Jairath M; Asker DS; Timbrell JA
    Eur J Pharmacol; 1995 Jul; 293(2):141-9. PubMed ID: 7589228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt.
    Gonçalves DA; Silveira WA; Lira EC; Graça FA; Paula-Gomes S; Zanon NM; Kettelhut IC; Navegantes LC
    Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E123-33. PubMed ID: 21952035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of β-adrenergic signaling in PGC-1α-mediated adaptations in mouse skeletal muscle.
    Brandt N; Nielsen L; Thiellesen Buch B; Gudiksen A; Ringholm S; Hellsten Y; Bangsbo J; Pilegaard H
    Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E1-E20. PubMed ID: 28874356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.